These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 17374389)

  • 61. Modelling the epidemiology, transmission and control of lymphatic filariasis.
    Das PK; Subramanian S
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S153-64. PubMed ID: 12625928
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.
    Ismail MM; Weil GJ; Jayasinghe KS; Premaratne UN; Abeyewickreme W; Rajaratnam HN; Sheriff MH; Perera CS; Dissanaike AS
    Trans R Soc Trop Med Hyg; 1996; 90(6):684-8. PubMed ID: 9015519
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania.
    Simonsen PE; Magesa SM; Dunyo SK; Malecela-Lazaro MN; Michael E
    Trans R Soc Trop Med Hyg; 2004 Aug; 98(8):462-72. PubMed ID: 15186934
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.
    Babu BV; Kar SK
    Trop Med Int Health; 2004 Jun; 9(6):702-9. PubMed ID: 15189460
    [TBL] [Abstract][Full Text] [Related]  

  • 65. An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
    Jambulingam P; Kuttiatt VS; Krishnamoorthy K; Subramanian S; Srividya A; Raju HKK; Rahi M; Somani RK; Suryaprakash MK; Dwivedi GP; Weil GJ
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009069. PubMed ID: 33591979
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of albendazole in programmes to eliminate lymphatic filariasis.
    Ottesen EA; Ismail MM; Horton J
    Parasitol Today; 1999 Sep; 15(9):382-6. PubMed ID: 10461168
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
    Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
    Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Elimination of transmission of lymphatic filariasis in Egypt.
    Molyneux DH
    Lancet; 2006 Mar; 367(9515):966-8. PubMed ID: 16564345
    [No Abstract]   [Full Text] [Related]  

  • 69. Comparative efficacy of clearing-dose and single high-dose ivermectin and diethylcarbamazine against Wuchereria bancrofti microfilaremia.
    Addiss DG; Eberhard ML; Lammie PJ; McNeeley MB; Lee SH; McNeeley DF; Spencer HC
    Am J Trop Med Hyg; 1993 Feb; 48(2):178-85. PubMed ID: 8447520
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lymphatic filariasis in the coastal areas of Digha, West Bengal, India.
    Chandra G; Chatterjee SN; Das S; Sarkar N
    Trop Doct; 2007 Jul; 37(3):136-9. PubMed ID: 17716494
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lymphatic filariasis elimination efforts in Rufiji, southeastern Tanzania: decline in circulating filarial antigen prevalence in young school children after twelve rounds of mass drug administration and utilization of long-lasting insecticide-treated nets.
    Jones C; Ngasalla B; Derua YA; Tarimo D; Malecela MN
    Int J Infect Dis; 2017 Aug; 61():38-43. PubMed ID: 28527817
    [TBL] [Abstract][Full Text] [Related]  

  • 72. School-based health education campaign--a potential tool for social mobilization to promote the use of DEC-fortified salt towards elimination of lymphatic filariasis.
    Nandha B; Krishnamoorthy K
    Health Educ Res; 2007 Aug; 22(4):539-46. PubMed ID: 17035351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west Ethiopia.
    Endeshaw T; Taye A; Tadesse Z; Katabarwa MN; Shafi O; Seid T; Richards FO
    Pathog Glob Health; 2015; 109(7):344-51. PubMed ID: 26878935
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 75. Double blind study on efficacy and safety of single doses of ivermectin and diethylcarbamazine for treatment of Polynesian Wuchereria bancrofti carriers. Results at six months.
    Cartel JL; Spiegel A; Nguyen L; Genelle B; Roux JF
    Trop Med Parasitol; 1991 Mar; 42(1):38-40. PubMed ID: 2052854
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.
    Nicolas L; Plichart C; Nguyen LN; Moulia-Pelat JP
    J Infect Dis; 1997 Feb; 175(2):489-92. PubMed ID: 9203681
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Comparative efficacy of annual and semi-annual doses of ivermectin or diethylcarbamazine for the prevention of lymphatic filariasis].
    Cartel JL; Spiegel A; Nguyen L; Moulia-Pelat JP; Martin PM; Roux JF
    Rev Epidemiol Sante Publique; 1992; 40(5):307-12. PubMed ID: 1480807
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Efficacy of ivermectin for control of microfilaremia recurring after treatment with diethylcarbamazine: immunological observation].
    Zheng HJ; Tao ZH; Cheng WF; Wang SH; Cheng SZ; Ye YM; Luo LF; Chen XR; Gan GB; Piessens WF
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 1993; 11(1):33-7. PubMed ID: 8403274
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis.
    Horton J; Witt C; Ottesen EA; Lazdins JK; Addiss DG; Awadzi K; Beach MJ; Belizario VY; Dunyo SK; Espinel M; Gyapong JO; Hossain M; Ismail MM; Jayakody RL; Lammie PJ; Makunde W; Richard-Lenoble D; Selve B; Shenoy RK; Simonsen PE; Wamae CN; Weerasooriya MV
    Parasitology; 2000; 121 Suppl():S147-60. PubMed ID: 11386686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.